ADAM17 cleaves MerTK to control macrophage inflammatory responses in steatotic livers, but this compensation fails in NASH – possibly due to reduced availability of HSC-supplied vitamin A (which is depleted when HSCs activate) that is necessary to stimulate ADAM17 (100). This evidence concerns the gene ADAM17 and metabolic dysfunction-associated steatohepatitis.